Viewing Study NCT01353469


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2025-12-25 @ 8:19 PM
Study NCT ID: NCT01353469
Status: COMPLETED
Last Update Posted: 2013-02-27
First Post: 2011-05-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Assessment of Efficacy and Safety of Insuman Comb 25 Versus NovolinĀ® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module